HD-OPM Archive
Topics › Aging & longevity

Senescent cells may drive atherosclerosis, making senolytics a possible target

Louis Nervegna · Nov 07, 2025 · ♥ 4 reactions · 0 comments · original Facebook post
Aging & longevityBlood vessels, circulation & endothelium
AI summary & key facts

Louis suggests that senescent cells, which accumulate with age, are a causal factor in atherosclerosis, especially in the endothelium, and that drugs targeting them might help. The shared AFAR post notes mouse studies show senescent cells can be removed.

Senescent cells are a causal factor in atherosclerosis, particularly in the delicate endothelium. The older you get, the more of your cells ultimately become senescent. Drugs (or supplements) that target these cells might prevent and treat heart disease.

#senescenceHD #senolyticsHD #saspHD

View from AFAR: “Zombie” Cells and Healthy Aging

Halloween may be over, but the “zombie” cells hiding in your body are here year-round!

In scientific terms, these are senescent cells – cells that have stopped dividing but don’t die. As we age, they can accumulate in tissues and secrete harmful molecules that degrade surrounding tissue, contributing to the decline of organ function.

While once controversial, research now shows that senescent cells play a damaging role in aging, but the good news is that they can be removed. Studies in mice have shown that it was possible to reduce the burden of senescent cells – extending not just lifespan, but healthspan.

Steven N. Austad, PhD, AFAR Scientific Director, explains:

"These 'zombie' cells are like a ticking time bomb in our tissues. They’ve lost their ability to perform their normal function, and they now can damage surrounding cells. The exciting part is that we now have strategies to selectively remove them, offering a potential path to healthier aging."

AFAR Grantee and Board Member James L. Kirkland, MD, PhD, has been a trailblazer in advancing senolytic therapies to remove these cells. Many other AFAR grantees are building on this foundational research.

To learn more about senescence and senolytics, read AFAR’s two-part Ask the Expert Interview series with Dr. Kirkland here:

afar.orgJames kirkland md phd on senescence research and early senolytics partafar.org

#ViewFromAFAR #HealthyAging #Gerotherapeutics #CellularSenescence

No photo description available.
← newer: Statins, ezetimibe and PCSK9 drugs reverse plaque once LDL iolder: How the liver metabolizes alcohol and why a few drinks linge →